Quantitative evaluation of the benefit of fiducial image-guidance for prostate cancer intensity modulated radiation therapy using daily dose volume histogram analysis

Technology in Cancer Research and Treatment

Volumn 13, Issue 1, 2014, Pages 47-55

  Kasaova, L ^a,b   Sirak, I ^a   Jansa, J ^a,c   Paluska, P ^a,c   Petera, J ^a,c  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dose volume histogram; Fiducial markers; Prostate radiotherapy; Safety margin

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FIDUCIAL MARKER; HISTOGRAM; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RADIATION DOSE; RADIOTHERAPY PLANNING SYSTEM; TUMOR VOLUME;

FIDUCIAL MARKERS; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892757905     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500352     Document Type: Article

References (28)

1. Kuban, D. A., Tucker, S. L., Dong, L., Starkschall, G., Huang, E. H., Cheung, M. R., Lee, A. K., Pollack, A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiation Oncology Biol Phys 70, 67-74 (2008). DOI: 10.1016/j.ijrobp.2007.06.054
2. Zietman, A. L., DeSilvio, M. L., Slatter, J. D., Rossi, C. J., Miller, D. W., Adams, J. A., Shipley, W. U. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294, 1233-1239 (2005). DOI: 10.1001/jama.294.10.1233
3. Byrne, T. A. Review of prostate motion with considerations for the treatment of prostate cancer. Med Dosim 30, 155-161 (2005). DOI: 10.1016/j.meddos.2005.03.005
4. Langen, K. M., Jones, D. T. L. Organ motion and its management. Int J Radiation Oncology Biol Phys 50, 265-278 (2001). DOI: 10.1016/S0360-3016(01)01453-5
5. Peeters, S. T. H., Heemsbergen, W. D., Koper, P. C. M., van Putten, W. L. J., Slot, A., Dielwart, M. F. H., Bonfrer, J. M. G., Incrocci, L., Lebesque, J. V. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III comparing 68 Gy of radiotherapy with 78 Gy. Journal of Clinical Oncology 24, 1990-1996 (2006). DOI: 10.1200/JCO.2005.05.2530
6. Fiorino, C., Valdagni, R., Rancati, T., Sanguineti, G. Dose-volume effect for normal tissues in external radiotherapy: Pelvis. Radiotherapy and Oncology 93, 153-167 (2009). DOI: 10.1016/j.radonc.2009.08.004
7. Taussky, D., Schneider, U., Rousson, V., Pescia, R. Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate. American Journal of Clinical Oncology 26, 144-149 (2003).
8. Pawlowski, J. M., Yang, E. S., Malcolm, A. W., Coffey, C. W., Ding, G. X. Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy. Int J Radiation Oncology Biol Phys 76, 924-934 (2010). DOI: 10.1016/j.ijrobp.2009.06.068
9. Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., Rosen, I. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiation Oncology Biol Phys 53, 1097-1105 (2002). DOI: 10.1016/S0360-3016(02)02829-8
10. Zelefsky, M. J., Yamada, Y., Fuks, Z., Zhang, Z., Hunt, M., Cahlon, O., Park, J., Shippy, A. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiation Oncology Biol Phys 71, 1028-1033 (2008). DOI: 10.1016/j.ijrobp.2007.11.066
11. Kasaova, L., Sirak, I., Jansa, J., Paluska, P., Petera, J. Daily prostate volume and position monitoring using implanted gold markers and on-board imaging during radiotherapy. Acta Medica 54, 149-152 (2011).
12. Van Herk, M. Errors and margins in radiotherapy. Seminars in Radiation Oncology 14, 52-64 (2004). DOI: 10.1053/j.semradonc.2003.10.003
13. Wu, Q., Mohan, R., Niemierko, A., Schmidt-Ullrich, R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiation Oncology Biol Phys 52, 224-235 (2002). DOI: 10.1016/S0360-3016(01)02585-8
14. Burman, C., Kutcher, G. J., Emami, B., Goitein, M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiation Oncology Biol Phys 21, 123-135 (1991). DOI: 10.1016/0360-3016(91)90172-Z
15. D'Agostino, R. B., Belanger, A., D'Agostino, R. B. Jr. A suggestion for using powerful and informative tests of normality. The American Statistician 44, 316-321 (1990). DOI: 10.1080/00031305.1990.10475751
16. Stroom, J. C., Heijmen, B. J. M. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiotherapy and Oncology 64, 75-83 (2002). DOI: 10.1186/1748-717X-2-44, DOI: 10.1016/S0167-8140(02)00140-8
17. Barney, B. M., Lee, R. J., Handrahan, D., Welsh, K. T., Cook, J. T., Sause, W. T. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiation Oncology Biol Phys 80, 301-305 (2011). DOI: 10.1016/j.ijrobp.2010.06.007
18. Skarsgard, D., Cadman, P., El-Gayed, A., Pearcey, R., Tai, P., Pervez, N., Wu, J. Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers. Radiation Oncology 5, 52-63 (2010).
19. Beltran, C., Herman, M. G., Davis, B. J. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiation Oncology Biol Phys 70, 289-295 (2008). DOI: 10.1016/j.ijrobp.2007.08.040
20. Tudor, G. S. J., Rimmer, Y. L., Nguyen, T. B., Cowen, M. A., Thomas, S. J. Consideration of the likely benefit from implementation of prostate image-guided radiotherapy using current margin sizes: a radiobiological analysis. British Journal of Radiology 85, 1263-1271 (2012). DOI: 10.1259/bjr/27924223
21. Miles, E. F., Nelson, J. W., Alkaissi, A. K., Das, S., Clough, R. W., Anscher, M. S., Oleson, J. R. Equivalent uniform dose, D90 and V100 correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer. Brachytherapy 7,206-211 (2008). DOI: 10.1016/j.ijrobp.2009.04.052
22. Moiseenko, V., Liu, M., Kristensen, S., Gelowitz, G., Berthelet, E. Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study. J Appl Clin Med Phys 8, 55-68 (2007).
23. Harsolia, A., Vargas, C., Yan, D., Brabbins, D., Lockman, D., Liang, J., Gustavson, G., Vicini, F., Martinez, A., Kestin, L. L. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of phase II dose-escalation study. Int J Radiation Oncology Biol Phys 69, 1100-1109 (2007). DOI: 10.1016/j.ijrobp.2007.04.076
24. Cheung, M. R., Tucker, S. L., Dong, L., de Crevoisier, R., Lee, A. K., Frank, S., Kudchadker, R. J., Thames, H., Mohan, R., Kuban, D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiation Oncology Biol Phys 67, 1059-1065 (2007). DOI: 10.1016/j.ijrobp.2006.10.042
25. Pederson, A. W., Fricano, J., Correa, D., Pelizzari, C. A., Liauw, S. L. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiation Oncology Biol Phys 82, 235-241 (2012). DOI: 10.1016/j.ijrobp.2010.09.058
26. Fiorino, C., Cozzarini, C., Vavassori, V., Sanguineti, G., Bianchi, C., Cattaneo, G. M., Foppiano, F., Magli, A., Piazzolla, A. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiotherapy and Oncology 64, 1-12 (2002). DOI: 10.1016/S0167-8140(02)00147-0
27. Huang, E. H., Pollack, A., Levy, L., Starkschall, G., Dong, L., Rosen, I., Kuban, D. A. Late rectal toxicity: dose volume effect of rectal toxicity of conformal radiotherapy for prostate cancer. Int J Radiation Oncology Biol Phys 54, 1314-1321 (2002). DOI: 10.1016/S0360-3016(02)03742-2
28. Paluska P., Hanus, J., Sefrova, J., Rouskova, L., Grepl, J., Jansa, J., Kasaova, L., Hodek, M., Zouhar, M., Vosmik, M., Petera, J. Utilization of cone-beam CT for offline evaluation of target volume coverage during prostate image guided radiotherapy based on bony anatomy alignment. Reports of Practical Oncology and Radiotherapy 3, 134-140 (2012). DOI: 10.1016/j.rpor.2012.03.003